Kalidex Pharmaceuticals

Kalidex Pharmaceuticals is a privately held anti-infective company creating the next generation of quinolones to help address the global problem of emerging infections caused by MDR organisms. Kalidex was cofounded in 2010 by Drs. James Ge, Vernocn Jiang and George H. Talbot, along with Frazier Healthcare Ventures. Kalidex's team has a track record of recent successes in the clinical development of antibacterials (gemifloxacin, doripenem, ceftaroline, and CXA-201).

Kalidex Pharmaceuticals is a privately held anti-infective company creating the next generation of quinolones to help address the global problem of emerging infections caused by MDR organisms. Kalidex was cofounded in 2010 by Drs. James Ge, Vernocn J...Show all

Company (Alive / Active)

All investors data 6 Investors

• Canaan Partners
• Domain Associates
• Frazier Healthcare Partners
• MPM Capital
• New Leaf Venture Partners

Board Members

Competitors

Patents